Melinta Therapeutics Inc. (MLNT) Declined -12.33% or -0.9 To Price $6.4 On Tuesday


Melinta Therapeutics Inc. (MLNT) declined -12.33% or -0.9 to $6.4. It is nearly 584752 shares traded, which is 424.09% compare to the average total volume 137885. The market cap of MLNT is $200.66 million. The year to date change is -55.89%. The 52 week price range is from $6.4 to $24.25. Price of MLNT have changed -2.01% during last week. It have changed 5.04% over last month, -43.19% over last 3 months, -45.52% over last 6 months and -62.08% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MLNT is 8.08. It is 26.25% above current price. The 200-day Moving Averages for MLNT is 13.08. It is 104.37% above current price. The 52-week High is 24.25. It is 278.91% from the current price. The 52-week Low is 6.4. The stock hits 52-week low today.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MLNT is 9.64 on 2018-04-30. Short % to float is 5.29%. There are some statistics of MLNT. It is has market cap $200.66 million. The share outstanding is 31.35 million. The average volume is 137885. The revenue is 2.58M. It has 363.14M cash and 22.36M in debt. The percent of top 15 Institution holding is 77.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MLNT is -56.15%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MLNT is -30.89%.


Tags:

Share this post